Showing results (181-190 of 378) with videos related to

Sort By:
Pageof 38
European Urology|May 23, 2024
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic ReviewAdam B Weiner, Preeti Kakani, Andrew J Armstrong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2004
Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvementElizabeth J Adams, David J Convery, Vivian P Cosgrove, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2025
ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysisFilippo Alongi, Francesco Cuccia, Rupesh Kotecha, et al.
Stroke (Hoboken, N.J.)|July 6, 2026
Diagnostic Accuracy of Ischemia and Hemorrhage on Cone-Beam CT Immediately After Endovascular ThrombectomyLovisa Landström, Henrik Andersson, Mattias Drake, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 21, 2006
Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast indurationSonja Brooker, Susan Martin, Ann Pearson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 10, 2005
Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapyLone Gothard, Paul Cornes, Sonja Brooker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2019
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE TrialJulia R Murray, Alison C Tree, Emma J Alexander, et al.
Journal of the National Cancer Institute|September 4, 2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial)David P Dearnaley, Matthew R Sydes, Malcolm D Mason, et al.
Pageof 38